29. Survival at predefined time points for all cancer patients, long term follow up studies only*.

	On study mortality data set			Overall survival data set
Time after date of randomization	Deaths	ESA versus control HR (95% CI)**	P value	Deaths	ESA versus control HR (95% CI)*	P value
At 4 months	790	1.22 (95% CI 1.06‐1.41)	0.005	965	1.17 (95% CI 1.03‐1.33)	0.015
At 8 months	970	1.25 (95% CI 1.10‐1.42)	0.001	2023	1.08 (95% CI 0.99‐1.18)	0.097
At 12 months	1050	1.26 (95% CI 1.11‐1.42)	<0.001	2823	1.08 (95% CI 1.00‐1.16)	0.046
At 24 months	‐	‐	‐	3743	1.07 (95% CI 1.01‐1.15)	0.032
At 36 months	‐	‐	‐	4028	1.06 (95% CI 0.99‐1.13)	0.077
At 60 months	‐	‐	‐	4169	1.07 (95% CI 1.00‐1.13)	0.041

*8974 patients from all treatment populations stemming from trials designed for long term follow up were under observation. 
 **based on Cox fixed‐effects model stratified by study